Introduction: Escherichia coli has been described as the major cause of neonatal and weaned pig diarrhea and death in pigs (Bertschinger et al., 1992) . Mortality and loss of productivity from edema disease cost the U.S. swine industry millions of dollars annually. The treatment of choice for an outbreak of enterotoxigenic E. coli has been antibiotics; however, due to antibiotic resistance, new control methods need to be explored. There appears to be global interest in the use of probiotics and competitive exclusion cultures as alternatives to antibiotics. The theory of competitive exclusion cultures works on the premise that when an animal is born, the intestinal tract is a sterile environment with none of the microflora found in healthy adults of that species. The absence of the normal microflora in the neonate predisposes it for colonization by enteropathogens. If adult microflora is administered to neonates, the gut will be colonized by commensal bacteria earlier than what would occur naturally and the neonate will be more resistant to colonization by enteropathogens (Nurmi and Rantala, 1973; Lloyd et al., 1977) . Some mechanisms by which commensal bacteria block colonization by pathogens include competition for nutrients, occupation of receptor and attachment sites, and production of bactericidal compounds. Our laboratory developed a defined, porcinederived, mixed culture of commensal bacteria designated RPCF. In vitro, RPCF has prevented colonization by Salmonella and E. coli (Harvey et al., 2002) . In laboratory challenge studies with enterotoxigenic E. coli, RPCF-treated pigs had reduced mortality, decreased shedding, and decreased gut concentrations of E. coli compared to controls (Genovese et al., 2000 (Genovese et al., , 2001 . The objective of the O 52
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ORAL PRESENTATIONS ORAL PRESENTATIONS present study was to evaluate the efficacy of RPCF to prevent or reduce disease associated with enterotoxigenic strains of E. coli in nursery-age pigs in commercial operations. +Materials and Methods: Five farms (four nursery and one wean-to-finish) from various geographic regions of the U.S. that had been diagnosed with enterotoxigenic (F-18 strain) E. coli disease were selected for participation in these trials. Each farm had a history of high mortality from F-18 strain. Nine sow units supplied weaned pigs to these farms. Piglets were orally dosed with 10 8 colony-formingunits of RPCF within 24 h of birth, and performance records were measured from birth throughout the nursery period. Measurements included weaning weights and weaning mortality at the sow farm and average daily weight gain, feed consumption, feed efficiency, mortality and culls, and medication costs in the nurseries. A total of 34,676 pigs were included on trials and 20,217 piglets were treated with RPCF.
Results and Discussion:
Disease associated with E. coli was reduced on each of the five farms. The most obvious improvement seen with RPCF treatments was decreased mortality and culls ( Table 1) . These results are similar to those seen in laboratory studies in which RPCF-treated piglets had reduced mortality, shedding, reduced organ invasion, and decreased GI tract concentrations when challenged with a 987p strain of E. coli (Genovese et al., 2000 (Genovese et al., , 2001 . In the present study, cull losses were combined with mortality losses because the authors felt this was a more objective measure of morbidity and overall health of the herds. When mortality alone was measured, most of the RPCF-treated groups were at 1 % or less (data not shown). Decreased medication costs were calculated on four of the five farms. When projected to an annual basis, the medication cost savings were: Farm 1 = 1048 ($), Farm 3 = 18,765 ($), Farm 4 = 2970 ($), and Farm 5 = 7560 ($). The cost benefits to the producers from mortality reductions varied depending upon the size of the farm, but averaged 22,196 ($) per farm (Table 1) . Cost benefits were calculated thusly: Mortality percentage difference X annual number of pigs grown X 50 ($) per pig = annual value; Medication cost difference per pig X annual number of pigs grown = annual value. On an annual basis, Farm 1 produced 2600 pigs, Farm 2 produced 8000 pigs, and Farms 3, 4, and 5 produced 27,000 pigs each. There were no consistent differences observed between treatments for weaning weights or weaning mortality or for feed consumption, feed efficiency, or average daily gain. The results from these trials demonstrate that RPCF is able to reduce mortality and morbidity and reduce medication costs associated with field challenge from F-18 strains of E. coli. Although RPCF is not commercially available at present, once marketed it could become an alternative to antibiotics in the control of enterotoxigenic E. coli. Table 1 . RPCF improves profitability on E. coli problem farms
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